/ Print /

Staying compliant with a prescribed treatment regimen gives cardiovascular disease patients the best chance of improving their heart health and reducing future incidences of cardiac events. Here’s how to get patients on board.
A report from the Department of Health and Human Services indicates positive momentum in efforts to combat hospital-acquired conditions, but experts say more can be done.
A glimpse into the present and future of healthcare industry mergers and acquisitions
Heart disease takes a heavy toll on the healthcare system, but promising new treatments are emerging
Your input is needed! Managed Healthcare Executive, in partnership with Access Market Intelligence and the National Institute of Collaborative Healthcare, is seeking your opinion on the current state of pharmacy, and where it’s headed...
Here are some of the innovative approaches payers and providers are taking to quell the diabetes epidemic, and curb the costs associated with it.
Concerns among stakeholders may call for EHR system revamping
An in-depth look at the effects of PDMPs, which are electronic databases used to track the prescribing and dispensing of controlled prescription drugs to patients.
While value-based reimbursement presents opportunities for payers and providers, succeeding in such a reimbursement model can be challenging. Here are four things to strive for that could increase the likelihood of success in a value-...
Model set to improve compliance, reduce costs, but reimbursement challenges remain.

IN THE PIPELINE
Why new bladder cancer drug is novel

FDA recently granted accelerated approval for atezolizumab (Tecentriq, Genentech), the first drug for bladder cancer that ...

FDA warns about popular diabetes drugs
New treatment for kidney cancer gets OK
Opdivo snags two new cancer approvals

INDUSTRY ANALYSIS
Lessons learned from MSSP ACOs: What ...

Researchers from Leavitt Partners are using a combination of public and proprietary data to report on some early findings ...

Public opinion shifts about the ACA
Presidential candidates’ ACA plans
Supreme Court Zubik v. Burwell: ...

PHARMACY BEST PRACTICES
Will price impede recently approved ...

Probuphine implant could be a new option for addicts if obstacles, such as price, don’t get in the way.

Three ways to maximize value in ...
Opinion: Top 4 lessons learned from ...
New payer trends for opioids ...

ACCOUNTABLE CARE
Top 5 ways value-based pricing ...

With new requirements from CMS on the horizon, how will the shift to value-based care impact consumers, payers, and ...

Blue Shield of California CEO shares ...
Pharmacists critical to success in 5 ...
ACOs that include hospitals have ...

POLICY
SCOTUS Ruling on False Claims Act ...

The industry is awaiting the Supreme Court’s ruling on Universal Health Services v. Escobar. This case concerns the ...

Seven ways Hillary Clinton would ...
How Trump would change healthcare
How Trump, Cruz, and Kasich would ...

BLOGS
Opinion: Captive insurance models ...

Captives can serve as focal points for the captive owners’ collective efforts to promote safer healthcare environments ...

Study: Biosimilars may result in ...
Four big post-ACA challenges for payers
Landmark study: Intensive blood ...

FOR YOUR BENEFIT
Lessons learned from MSSP ACOs: What ...

Researchers from Leavitt Partners are using a combination of public and proprietary data to report on some early findings ...

Health execs: Advice I would give my ...
Measuring payer, provider progress ...
Common skills shared by successful ...

Latest Issue

Find us on Facebook

Follow Us On Twitter

Latest Tweets Follow